Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

A validated capillary electrophoresis method for simultaneous determination of ezetimibe and atorvastatin in pharmaceutical formulations.

Alshehri MM.

Saudi Pharm J. 2012 Apr;20(2):143-8. doi: 10.1016/j.jsps.2011.09.005. Epub 2011 Sep 24.

2.

The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years.

Ben-Yehuda O, Wenger NK, Constance C, Zieve F, Hanson ME, Lin JX, Shah AK, Jones-Burton C, Tershakovec AM.

J Geriatr Cardiol. 2011 Mar;8(1):1-11. doi: 10.3724/SP.J.1263.2011.00001.

3.
4.

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study.

Hing Ling PK, Civeira F, Dan AG, Hanson ME, Massaad R, De Tilleghem Cle B, Milardo C, Triscari J.

Lipids Health Dis. 2012 Jan 31;11:18. doi: 10.1186/1476-511X-11-18.

5.

Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial.

Shekhar Pandey A, Bissonnette S, Boukas S, Rampakakis E, Sampalis JS.

Arch Med Sci. 2011 Oct;7(5):767-75. doi: 10.5114/aoms.2011.25550. Epub 2011 Nov 8.

7.

Response by sex to statin plus ezetimibe or statin monotherapy: a pooled analysis of 22,231 hyperlipidemic patients.

Abramson BL, Benlian P, Hanson ME, Lin J, Shah A, Tershakovec AM.

Lipids Health Dis. 2011 Aug 22;10:146. doi: 10.1186/1476-511X-10-146.

8.

Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?

Bays H, Conard S, Leiter LA, Bird S, Jensen E, Hanson ME, Shah A, Tershakovec AM.

Lipids Health Dis. 2010 Nov 30;9:136. doi: 10.1186/1476-511X-9-136.

9.

Ezetimibe/simvastatin 10/20 mg versus rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency.

Viigimaa M, Vaverkova H, Farnier M, Averna M, Missault L, Hanson ME, Dong Q, Shah A, Brudi P.

Lipids Health Dis. 2010 Nov 4;9:127. doi: 10.1186/1476-511X-9-127.

10.

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes.

Rotella CM, Zaninelli A, Le Grazie C, Hanson ME, Gensini GF.

Lipids Health Dis. 2010 Jul 27;9:80. doi: 10.1186/1476-511X-9-80.

11.

Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study).

Bardini G, Giorda CB, Pontiroli AE, Le Grazie C, Rotella CM.

Cardiovasc Diabetol. 2010 May 21;9:20. doi: 10.1186/1475-2840-9-20.

12.

Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients.

Chow D, Chen H, Glesby MJ, Busti A, Souza S, Andersen J, Kohrs S, Wu J, Koletar SL.

AIDS. 2009 Oct 23;23(16):2133-41. doi: 10.1097/QAD.0b013e32833068e3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk